Načítá se...
MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease associated with dysfunction of pulmonary artery endothelial cells and pulmonary artery smooth muscle cells (PASMCs). To explore the potential mechanism of miR-193-3p in pulmonary arterial hypertension, human PASMCs and...
Uloženo v:
| Vydáno v: | Pulm Circ |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734527/ https://ncbi.nlm.nih.gov/pubmed/33354317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020974919 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|